ANDREW S. MASLAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Nuo Therapeutics, Inc.

Filing Date Source Excerpt
2012-04-16 Andrew S. Maslan - Chief Financial Officer of the Company. Includes 367,275 shares Mr. Maslan may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan and warrants.
2013-04-26 Andrew S. Maslan - Includes 401,218 shares Mr. Maslan may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan and warrants. Mr. Maslan tendered his resignation as the Company’s Chief Financial Officer on March 29, 2013, effective as of May 10, 2013.

Data sourced from SEC filings. Last updated: 2026-02-03